Literature DB >> 1812719

Proteolytic activation of human procathepsin D.

G Richo1, G E Conner.   

Abstract

Procathepsin D is a short-lived inactive precursor of the lysosomal aspartyl protease, cathepsin D. Pulse-chase analysis using radiolabeled amino acids demonstrated the existence of several biosynthetic intermediates during formation of mature cathepsin D (summarized in Figure 1). Procathepsin D is capable of autocatalytic cleavage to pseudocathepsin D. This was demonstrated using small quantities of procathepsin D isolated from cell culture media as well as using a non-glycosylated form of procathepsin D synthesized in a bacterial expression system. Complete conversion to the single-chain cathepsin D appears to require a second enzyme which is inhibited by leupeptin. This conclusion was drawn from the inability to produce single-chain enzyme from either procathepsin D or pseudocathepsin D in vitro as well as observations from addition of protease inhibitors to cell cultures. It appears that the conversion of procathepsin D to active single-chain enzyme falls between the paradigms of pepsinogen autoactivation and prorenin conversion by a separate enzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812719     DOI: 10.1007/978-1-4684-6012-4_35

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Modulation of cathepsin D activity in retinal pigment epithelial cells.

Authors:  P E Rakoczy; C M Lai; M Baines; S Di Grandi; J H Fitton; I J Constable
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

2.  Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B.

Authors:  Valérie Laurent-Matha; Danielle Derocq; Christine Prébois; Nobuhiko Katunuma; Emmanuelle Liaudet-Coopman
Journal:  J Biochem       Date:  2006-03       Impact factor: 3.387

3.  Procathepsin D and cancer: From molecular biology to clinical applications.

Authors:  Vaclav Vetvicka; Aruna Vashishta; Sujata Saraswat-Ohri; Jana Vetvickova
Journal:  World J Clin Oncol       Date:  2010-11-10

4.  Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation.

Authors:  Madanan Madathiparambil Gopalakrishnan; Hans-Wilhelm Grosch; Silvia Locatelli-Hoops; Norbert Werth; Eva Smolenová; Michael Nettersheim; Konrad Sandhoff; Andrej Hasilik
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

Review 5.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

6.  Proteolytic processing of the neuronal ceroid lipofuscinosis related lysosomal protein CLN5.

Authors:  Bhagya De Silva; Jessie Adams; Stella Y Lee
Journal:  Exp Cell Res       Date:  2015-09-03       Impact factor: 3.905

7.  Bi-allelic VPS16 variants limit HOPS/CORVET levels and cause a mucopolysaccharidosis-like disease.

Authors:  Kalliopi Sofou; Kolja Meier; Leslie E Sanderson; Debora Kaminski; Laia Montoliu-Gaya; Emma Samuelsson; Maria Blomqvist; Lotta Agholme; Jutta Gärtner; Chris Mühlhausen; Niklas Darin; Tahsin Stefan Barakat; Lars Schlotawa; Tjakko van Ham; Jorge Asin Cayuela; Fredrik H Sterky
Journal:  EMBO Mol Med       Date:  2021-05-03       Impact factor: 14.260

8.  Catalytically inactive human cathepsin D triggers fibroblast invasive growth.

Authors:  Valérie Laurent-Matha; Sharon Maruani-Herrmann; Christine Prébois; Mélanie Beaujouin; Murielle Glondu; Agnès Noël; Marie Luz Alvarez-Gonzalez; Sylvia Blacher; Peter Coopman; Stephen Baghdiguian; Christine Gilles; Jadranka Loncarek; Gilles Freiss; Françoise Vignon; Emmanuelle Liaudet-Coopman
Journal:  J Cell Biol       Date:  2005-01-24       Impact factor: 10.539

9.  Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Flora Guerra; Giulia Girolimetti; Raffaella Beli; Marco Mitruccio; Consiglia Pacelli; Anna Ferretta; Giuseppe Gasparre; Tiziana Cocco; Cecilia Bucci
Journal:  Cells       Date:  2019-05-14       Impact factor: 6.600

10.  Pro-domain removal in ASP-2 and the cleavage of the amyloid precursor are influenced by pH.

Authors:  Christina Sidera; Chibuu Liu; Brian Austen
Journal:  BMC Biochem       Date:  2002-08-31       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.